Vascular hypertrophy-associated hypertension of profilin1 transgenic mouse model leads to functional remodeling of peripheral arteries

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 6, 2010, Pages

  Hassona, Mohamed D H ^a,b,d   Abouelnaga, Zeinb A ^a,b   Elnakish, Mohammad T ^a,b,d   Awad, Mohamed M ^a,b,d   Alhaj, Mazin ^a,b   Goldschmidt Clermont, Pascal J ^c   Hassanain, Hamdy H ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d HELWAN UNIVERSITY   (Egypt)

Author keywords

Functional remodeling; Mesenteric arteries; Wire myograph

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACETYLCHOLINE; ALPHA1 INTEGRIN; BETA1 INTEGRIN; CYTOCHALASIN D; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROFILIN; PROTEIN C JUN; RHO KINASE; SODIUM NITRITE; VASOACTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY; ARTICLE; BLOOD VESSEL COMPLIANCE; BLOOD VESSEL FUNCTION; BLOOD VESSEL HYPERTROPHY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; HYPERTENSION; HYPERTROPHY; MALE; MESENTERIC ARTERY; MOUSE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESISTANCE BLOOD VESSEL; SIGNAL TRANSDUCTION; STRESS FIBER; TRANSGENIC MOUSE; VASCULAR DISEASE;

ANIMALS; ANTIGENS, CD29; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HYPERTENSION; HYPERTROPHY; INTEGRIN ALPHA1; MALE; MESENTERIC ARTERIES; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE III; PHENYLEPHRINE; PROFILINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 77952599107     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00016.2010     Document Type: Article

References (59)

1. Alvarez E, Northwood IC, Gonzalez FA, Latour DA, Seth A, Abate C, Curran T, Davis RJ. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem 266: 15277-15285, 1991. (Pubitemid 21907645)
2. Aplin AE, Howe A, Alahari SK, Uliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50: 197-263, 1998. (Pubitemid 28304026)
3. Belkin AM, Koteliansky VE. Interaction of iodinated vinculin, metavinculin and alpha-actinin with cytoskeletal proteins. FEBS Lett 220: 291-294, 1987.
4. Birukov KG, Bardy N, Lehoux S, Merval R, Shirinsky VP, Tedgui A. Intraluminal pressure is essential for the maintenance of smooth muscle caldesmon and filamin content in aortic organ culture. Arterioscler Thromb Vasc Biol 11: 922-927, 1998. (Pubitemid 28272586)
5. Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 119: 893-903, 1992.
6. Carlier MF, Pantaloni D. Control of actin assembly dynamics in cell motility. J Bio Chem 282: 23005-23009, 2007. (Pubitemid 47311896)
7. Chen HC, Appeddu PA, Parsons JT, Hildebrand JD, Schaller MD, Guan JL. Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 270: 16995-16999, 1995.
8. Cipolla MJ, Gokina NI, Osol G. Pressureinduced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 16: 72-127, 2002.
9. Egerton M, Ashe OR, Chen D, Druker BJ, Burgess WH, Samelson LE. VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell. EMBO J 11: 3533-3540, 1992.
10. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
11. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 62: 347-504, 1982.
12. Gibbos VJ, Dzau GH. The emerging concept of vascular remodeling. New Engl J Med 330: 1431-1438, 1994.
13. Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 99: 1809-1813, 1997.
14. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
15. Heerkens EH, Shaw L, Ryding A, Brooker G, Mullins JJ, Austin C, Ohanian V, Heagerty AM. alphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension 47: 281-287, 2006. (Pubitemid 43189775)
16. Higgs HN, Pollard TD. Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu Rev Biochem 70: 649-662, 2001.
17. Hildebrand JD, Schaller MD, Parsons JT. Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell 6: 637-647, 1995.
18. Hu Y, Cheng L, Hochleitner BW, Xy Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol 17: 2808-2816, 1997. (Pubitemid 28016025)
19. Huang MM, Lipfert L, Cunningham M, Brugge JS, Ginsberg MH, Shattil SJ. Adhesive ligand binding to integrin alpha IIb beta 3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK. J Cell Biol 122: 473-483, 1993. (Pubitemid 23210473)
20. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension 38: 581-587, 2001.
21. Ishida T, Peterson TE, KovACh NL, Berk BC. MAP kinase activation by flow in endothelial cells: role of beta 1 integrins and tyrosine kinases. Circ Res 79: 310-316, 1996. (Pubitemid 26255884)
22. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996. (Pubitemid 26285892)
23. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 267: 23439-23442, 1992. (Pubitemid 23088133)
24. Langille BL. Arterial remodeling: relation to hemodynamics. Can J Physiol Pharmacol 74: 834-841, 1996.
25. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HAJ. Microcirculation in hypertension-a new target for treatment? Circulation 104: 735-740, 2001. (Pubitemid 32738532)
26. Li S, Kim M, Hu YL, Jalali S, Schlaepfer DD, Hunter T, Chien S, Shyy JY. Fluid shear stress activation of focal adhesion kinase: linking to mitogen-activated protein kinases. J Biol Chem 272: 30455-30462, 1997. (Pubitemid 27512256)
27. Lo SH, Weisberg E, Chen LB. Tensin: a potential link between the cytoskeleton and signal transduction. Bioessays 16: 817-823, 1994. (Pubitemid 2161443)
28. 1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol 293: H2597-H2604, 2007.
29. Martin M, Vozenin MC, Gault N, Crechet F, Pfarr CM, Lefaix JL. Coactivation of AP-1 activity and TGF- 1gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene 15: 981-989, 1997. (Pubitemid 27399559)
30. Mazzatti DJ, Pawelec G, Jonath R, Forsey RJ. SELDI-TOF-MS proteinChip array profiling of T-cell propagated in long-term culture identifies human P potential bio-marker of immunosenescence. Proteome Sci 10: 1186-1477, 2007.
31. Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S, Yang Z. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22: 8467-8477, 2002. (Pubitemid 35397163)
32. Moustafa-Bayoumi M, Alhaj MA, El-Sayed O, Wisel S, Chotani MA, Abouelnaga ZA, Hassona MDH, Katya Rigatto Morris M, Nuovo G, Zweier JL, Goldschmidt-Clermont P, Hassanain H. Vascular hypertrophy and hypertension caused by transgenic overexpression of profilin 1. J Biol Chem 282: 37632-37639, 2007.
33. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, Takeshita A. Involvement of Rho-kinase in hypertensive vascular disease-a novel therapeutic target in hypertension. FASEB J 15: 1062-1064, 2001.
34. Mulvany MJ, BaumbACh GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension 28: 505-506, 1996.
35. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Shuh Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392: 189-193, 1996. (Pubitemid 26276745)
36. Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003.
37. Pyles JM, March K, Franklin M, Mehdi K, Wilensky RL, Adam LP. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res 8: 904-910, 1997. (Pubitemid 27514939)
38. Rao KM, Betschart JM, Virji MA. Hormone-induced actin polymerization in rat hepatoma cells and human leucocytes. Biochem J 230: 709-714, 1985. (Pubitemid 16236329)
39. Rao PV, Maddala R. The role of the lens actin cytoskeleton in fiber cell elongation and differentiation. Semin Cell Dev Biol 17: 698-711, 2006. (Pubitemid 46137018)
40. Raub O, Berk BC. Shear stress-mediated stimulation of ERK 1/2 in endothelial cells is regulated by Na+ channel. Circulation 96: I-50, 1997.
41. Rikitake Y, Kim H, Huang Z, Seto M, Yano K, Asano T, Moskowitz MA, Liao JK. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36: 2251-2257, 2005. (Pubitemid 41429255)
42. Romeo G, Frangioni JV, Kazlauskas A. Profilin acts downstream of LDL to mediate diabeticendothelialcell dysfunction. FASEB J 18: 725-727, 2004.
43. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor-null mouse. Circ Res 101: 357-367, 2007. (Pubitemid 47267704)
44. Sah VP, Seasholtz TM, Sagi SA. The role of Rho in G protein-coupled receptor signal transduction. Am Rev Pharmaco Toxicol 40: 459-489, 2000. (Pubitemid 30340690)
45. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 287: H435-H446, 2004.
46. Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH. Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res 89: 488-495, 2001. (Pubitemid 34132642)
47. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
48. Simon G. Pathogenesis of structural vascular changes in hypertension. J Hypertens 22: 3-10, 2004. (Pubitemid 38293520)
49. Suetsugu S, Miki H, Takenawa T. Distinct roles of profilin1 in cell morphological changes: microspikes, membrane ruffles, stress fibers, and cytokinesis. FEBS Lett 457: 470-474, 1999. (Pubitemid 29414745)
50. Tang DD, Tan J. Downregulation of profilin with antisense oligode-oxynucleotides inhibits force development during stimulation of smooth muscle. Am J Physiol Heart Circ Physiol 285: H1528-H1536, 2003. (Pubitemid 37169507)
51. Touyz RM. Vascular remodeling, retinal arteries, hypertension. Hypertension 50: 602-603, 2007.
52. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997. (Pubitemid 27485693)
53. Van der Loo B, Koppensteiner Luscher TFR. How do blood vessels age? Vasa 33: 3-11, 2004.
54. Wang L, Ellis MJ, Fields TA, Howell DN, Spurney RF. Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin amino-nucleoside nephrosis. Kidney Blood Press Res 31: 111-121, 2008. (Pubitemid 351630068)
55. Wang LC, Langille BL. Developmental remodeling of the internal elastic lamina of rabbit arteries: effect of blood flow. Circ Res 78: 799-805, 1996. (Pubitemid 126424514)
56. Weinreb O, Drigues N, Yotam Sagi Y, Abraham Reznick AZ Z, Tamar Amit T, Youdim M. The application of proteomics and genomics to the study of age-related neurodegeneration and neuroprotection. Antioxidants Redox Signal 9: 169-179, 2007. (Pubitemid 46115941)
57. Welser JV, Lange N, Singer CA, Elorza M, Scowen P, Keef KD, Gerthoffer WT, Burkin DJ. Loss of the alpha7 integrin promotes extracellular signal-regulated kinase activation and altered vascular remodeling. Circ Res 101: 672-681, 2007. (Pubitemid 47494098)
58. Witke W, Podtelejnikov AV, Di Nardo A, Sutherland JD, Gurniak CB, Dotti C, Mann M. In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly. EMBO J 17: 967-976, 1998. (Pubitemid 28077651)
59. Zhang ZH, Vuori K, Wang HG, Reed JC, Ruoslahti E. Integrin activation by R-Ras. Cell 85: 61-69, 1996.